DENALI THERAPEUTICS INC (DNLI:NASDAQ)
$25.68 -1.53 (-5.6229%)
Analysed DENALI THERAPEUTICS INC (DNLI:NASDAQ) News Sources
Denali Therapeutics' Focus Shifts to Other Pipeline Assets After Phase 2b Study Failure, Morgan Stanley Says
26-05-2026
yahoo.com
Denali Therapeutics Inc. (DNLI): One of the Top Stock Picks of Jeff Bezos
01-06-2026
yahoo.com
Biogen Ends BIIB122 Parkinsons Trial And Refocuses Neurodegeneration Pipeline
02-06-2026
yahoo.com
What Makes Denali Therapeutics (DNLI) One of the Best AI Driven Biotech Names
11-06-2026
yahoo.com
Acumen Nominates 2 Therapies to Treat Alzheimer’s Disease
16-06-2026
yahoo.com
Pfizer CFO to step down; Denali sells a regulatory fast-pass
18-06-2026
biopharmadive.com
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
18-06-2026
yahoo.com
Denali to Sell Priority Review Voucher for $195M Cash Boost
19-06-2026
yahoo.com
Regenxbio Shares Rise on Plans to Resubmit Navsunli BLA for MPS II
23-06-2026
yahoo.com
Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Barrier
09-07-2026
yahoo.com
What is the current price of DENALI THERAPEUTICS INC (DNLI:NASDAQ)?
The current price of DENALI THERAPEUTICS INC (DNLI:NASDAQ) is $25.68.
DENALI THERAPEUTICS INC (DNLI:NASDAQ) absolute price change since previous trading day?
The absolute price change of DENALI THERAPEUTICS INC (DNLI:NASDAQ) since the previous trading day is $-1.53.
DENALI THERAPEUTICS INC (DNLI:NASDAQ) percentage price change since previous trading day?
The percentage price change of DENALI THERAPEUTICS INC (DNLI:NASDAQ) since the previous trading day is -5.6229%.
What is the most recent average sentiment score for DENALI THERAPEUTICS INC (DNLI:NASDAQ)?
The most recent average sentiment score for DENALI THERAPEUTICS INC (DNLI:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for DENALI THERAPEUTICS INC (DNLI:NASDAQ)?
The most recent sentiment for DENALI THERAPEUTICS INC (DNLI:NASDAQ) is .
SEC-8K** Filing Available For DENALI THERAPEUTICS INC (DNLI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.